Filters (1)
![]() |
|
| |||
13 of 18 products in Gummies
(Brand:MediPharm Labs) ✕
ⓘ MediPharm Labs includes Re+Play
|
3.0 ★★★ ☆☆ (2) |
MediPharm Labs |
THC | 0mg/g (0.0%) | CBD V.HIGH | 15mg/g (15%) | CBD |
eweed.pro | BLEND | csmeter © |
$36.50* ![]() |
30g | $1.22/g |
Potency | CBD V.High | |
THC | 0mg/g | 0.0% |
CBD | 15mg/g | 15% |
CBN | 7.5mg/g | 7.5% |
Plant | Blend | |
Grown In | Ontario | |
Extraction | CO2 | |
Ingredients | See Nutrition Table | |
Producer | MediPharm Labs by MediPharm Labs Inc. | |
GTIN# | 00628639001238 (30g) |
MediPharm Labs CBN:CBD Soft Chews are a high-CBN Relax Wildberry formula containing 7.5mg/unit of CBN and 15mg/unit of CBD. Made using naturally derived, refined CBN material produced at MediPharm Labs using strict manufacturing standards to bring you the highest quality and purity. Each package contains 30 plant-based chews, using thoughtful ingredients with a burst of sweet, berry flavour.
A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.
Founded in 2015, MediPharm Labs Corp. is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation license. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification.
5.0 ★★★★★ |
A**L | May 2021 |
1.0 ★ ☆☆☆☆ |
M**C | Apr 2021 |